BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang K, Baldwin GS, Nikfarjam M, He H. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation. World J Gastroenterol 2018; 24(33): 3709-3723 [PMID: 30197477 DOI: 10.3748/wjg.v24.i33.3709]
URL: https://www.wjgnet.com/1007-9327/full/v24/i33/3709.htm
Number Citing Articles
1
Keita Yamada, Kiyoshi Higashi, Hirohisa Nagahori, Koichi Saito. Circulating natural antibodies against 3’-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarcinomaCancer Biomarkers 2019; 27(1): 121 doi: 10.3233/CBM-190158
2
Charudatt Samant, Ramesh Kale, Anand Bokare, Mahip Verma, K. Sreedhara Ranganath Pai, Mandar Bhonde. PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathwaysBiochemistry and Biophysics Reports 2023; 35: 101544 doi: 10.1016/j.bbrep.2023.101544
3
Ying Zhou, Jian Zhang, Jian Wang, Mao‐Sheng Cheng, Dong‐Mei Zhao, Feng Li. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1‐Related Signaling PathwaysThe Anatomical Record 2019; 302(9): 1571 doi: 10.1002/ar.24095
4
Baoyu Li, Bin Liu, Xianglian Zhang, Hui Liu, Lijie He. KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8Journal of Cellular Physiology 2020; 235(5): 4227 doi: 10.1002/jcp.29201
5
Weikang Kong, Lingxia Zhu, Tian Li, Jiao Chen, Bo Fan, Wenjing Ji, Chunli Zhang, Xueting Cai, Chunping Hu, Xiaoyan Sun, Peng Cao. Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancerEuropean Journal of Pharmacology 2023; 948: 175703 doi: 10.1016/j.ejphar.2023.175703
6
Arian Ansardamavandi, Mehrdad Nikfarjam, Hong He. PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic ResponseCells 2023; 12(23): 2692 doi: 10.3390/cells12232692
7
Hong He, Chelsea Dumesny, Ching-Seng Ang, Li Dong, Yi Ma, Jun Zeng, Mehrdad Nikfarjam. A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabineTranslational Oncology 2022; 16: 101329 doi: 10.1016/j.tranon.2021.101329
8
Chen Lu, Wei Jiang, Bingqing Hui, Dawei Rong, Kai Fu, Chaoxi Dong, Weiwei Tang, Hongyong Cao. The circ_0021977/miR‐10b‐5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancerJournal of Cellular Physiology 2020; 235(3): 2273 doi: 10.1002/jcp.29135
9
Dongdong Wang, Ji Zhu, Yuanqing Yang, Zhizhou Wang, Zhengran Ying, Hailong Zhang. The role of the miR-4306/PAK6 axis in degenerative nucleus pulposus cells in human intervertebral disc degenerationCellular Signalling 2023; 102: 110528 doi: 10.1016/j.cellsig.2022.110528
10
Wenting Wang, Zhijian Xu, Ning Wang, Ruyong Yao, Tao Qin, Hao Lin, Lu Yue. Prognostic value of eight immune gene signatures in pancreatic cancer patientsBMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-020-00868-w
11
Young-Lan Park, Sang-Yoon Ha, Sun-Young Park, Jung-Ho Choi, Min-Woo Jung, Dae-Seong Myung, Hyun-Soo Kim, Young-Eun Joo. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cellsInternational Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4746
12
Jian-Bo Shao, Xiang-Qian Luo, Li-Hua Mo, Gui Yang, Zhi-Qiang Liu, Jiang-Qi Liu, Zhi-Gang Liu, Da-Bo Liu, Ping-Chang Yang. Twist1 sustains the apoptosis resistance in eosinophils in nasal mucosa of allergic rhinitisArchives of Biochemistry and Biophysics 2021; 702: 108828 doi: 10.1016/j.abb.2021.108828
13
Nikolaos Symeonidis, Maria Lambropoulou, Efstathios Pavlidis, Constantinos Anagnostopoulos, Alexandra Tsaroucha, Athanasia Kotini, Christina Nikolaidou, Anastasia Kiziridou, Constantinos Simopoulos. PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic SignificanceClinical Medicine Insights: Oncology 2019; 13: 117955491983199 doi: 10.1177/1179554919831990
14
Qin Yang, Yingchao Zhao, Yeshan Chen, Yu Chang, Ai Huang, Tie Xu, Guiling Li, Gang Wu. PAK6 promotes cervical cancer progression through activation of the Wnt/β‑catenin signaling pathwayOncology Letters 2020; 20(3): 2387 doi: 10.3892/ol.2020.11797
15
Yi Ma, Mehrdad Nikfarjam, Hong He. The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinomaCancer Letters 2022; 548: 215868 doi: 10.1016/j.canlet.2022.215868
16
Mingzhe Li, Jiaxin Zhou, Zhengkui Zhang, Jisong Li, Feng Wang, Ling Ma, Xiaodong Tian, Zebin Mao, Yinmo Yang. Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1Chinese Medical Journal 2022; 135(19): 2326 doi: 10.1097/CM9.0000000000002154
17
Kinjal Shah, Julhash U. Kazi. Phosphorylation-Dependent Regulation of WNT/Beta-Catenin SignalingFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858782
18
Xiaodong Li, Feng Li. p21-Activated Kinase: Role in Gastrointestinal Cancer and BeyondCancers 2022; 14(19): 4736 doi: 10.3390/cancers14194736
19
Kai Wang, Yifan Zhan, Nhi Huynh, Chelsea Dumesny, Xiao Wang, Khashayer Asadi, David Herrmann, Paul Timpson, Yang Yang, Katrina Walsh, Graham S. Baldwin, Mehrdad Nikfarjam, Hong He. Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1Cancer Letters 2020; 472: 8 doi: 10.1016/j.canlet.2019.12.020
20
Kai Wang, Hong He. Tumor Microenvironments in OrgansAdvances in Experimental Medicine and Biology 2020; 1296: 243 doi: 10.1007/978-3-030-59038-3_15
21
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer ProgressionFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
22
Lizhou Xu, Farid N. Faruqu, Yau M. Lim, Kee Y. Lim, Revadee Liam-Or, Adam A. Walters, Paul Lavender, David Fear, Claire M. Wells, Julie Tzu-Wen Wang, Khuloud T. Al-Jamal. Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatmentBiomaterials 2021; 264: 120369 doi: 10.1016/j.biomaterials.2020.120369
23
Stefania Belli, Ada Pesapane, Alberto Servetto, Daniela Esposito, Fabiana Napolitano, Claudia Maria Ascione, Alessandra Allotta, Nicola Zambrano, Federica Zito Marino, Renato Franco, Teresa Troiani, Luigi Formisano, Roberto Bianco. Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancerBritish Journal of Cancer 2023; 129(7): 1071 doi: 10.1038/s41416-023-02390-z
24
Hsing-Yu Wu, Ming-Chen Yang, Li-Yun Ding, Ching S. Chen, Po-Chen Chu. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cellsCancer Letters 2019; 456: 13 doi: 10.1016/j.canlet.2019.04.026
25
Fangfang Zhuo, Shuang Luo, Wei He, Zhanhui Feng, Ya’nan Hu, Jingxia Xu, Zejun Wang, Jianwei Xu. The Role of Signaling Pathways in Pancreatic Cancer Targeted TherapyAmerican Journal of Clinical Oncology 2023; 46(3): 121 doi: 10.1097/COC.0000000000000979
26
Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Alaa A. A. Aljabali, Vijay Mishra, Yachana Mishra, Gowhar A. Naikoo, Sai Raghuveer Chava, Nitin B. Charbe, Murtaza M. Tambuwala. Impact of exosome therapy on pancreatic cancer and its progressionMedical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02101-x